CD8A and ovarian cancer: A meta-analysis of 10 studies evaluating the prognostic value of TILs on survival among patients with ovarian cancer, demonstrated that intraepithelial CD8 and CD3 TIL had a prognostic role, with CD8 TIL being a more robust prognostic factor, regardless of tumor subtype, grade, or disease stage (47).